Deficient Bordetella pertussis eIsolates in Iran with 50 Years Whole Cell Pertussis Vaccination

被引:1
|
作者
Saedi, Samaneh [1 ]
Safarchi, Azadeh [1 ]
Moghadam, Faranak Tayebzadeh [1 ]
Heidarzadeh, Siamak [2 ]
Nikbin, Vajihe Sadat [1 ]
Shahcheraghi, Fereshteh [3 ]
机构
[1] Pasteur Inst Iran, Dept Bacteriol, Tehran, Iran
[2] Zanjan Univ Med Sci, Sch Med, Dept Microbiol & Virol, Zanjan, Iran
[3] Pasteur Inst Iran, Dept Bacteriol, Pertussis Reference Lab, Tehran, Iran
关键词
Whooping cough; Bordetella pertussis; Iran; Whole-cell vaccine; Filamentous hemagglutinin; Pertactin; FIELD GEL-ELECTROPHORESIS; VIRULENCE FACTORS; SURFACE PROTEIN; PERTACTIN; EVOLUTION; EPIDEMIC; IMMUNIZATION; RESURGENCE; INCREASE; REVEALS;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Bordetella pertussis, a highly contagious respiratory. Notably, the resurgence of pertussis has recently been associated with the lacking production of vaccine virulence factors. This study aimed to screen pertactin (Prn) and filamentous hemagglutinin (Fha) production in Iran with 50 years' whole cell vaccine (WCV) immunization program. Methods: Overall, 130 B. pertussis isolates collected from Pertussis Reference Laboratory of Iran during 2005-2018. Real-time PCR was performed by targeting IS481, ptxP, IS1001 and IS1002 for species confirmation of B. pertussis. Western-blot was used to evaluate the expression of virulence factors (pertactin and filamentous hemagglutinin). Results: All tested B. pertussis isolates expressed Prn and all except two isolates expressed Fha. We have sequenced genomes of these strains and identified differences compared with genome reference B. pertussis Tohama I. Conclusion: Many countries reporting Prn and Fha-deficiency due to acellular vaccine (ACV) pressure. Our results demonstrate in a country with WCV history, Fha-deficient isolates may rise independently. However, Prn-deficient isolates are more under the ACV pressure in B. pertussis isolates. Continues surveillance will provide a better understanding of the effect of WCV on the evolution of the pathogen deficiency.
引用
收藏
页码:1454 / 1462
页数:9
相关论文
共 50 条
  • [1] Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination
    Polak, Maciej
    Zasada, Aleksandra Anna
    Mosiej, Ewa
    Krysztopa-Grzybowska, Katarzyna
    Witkowski, Lucjan
    Rzeczkowska, Magdalena
    Piekarska, Katarzyna
    Lutynska, Anna
    MICROBES AND INFECTION, 2019, 21 (3-4) : 170 - 175
  • [2] ISOTYPE AND ANTIGEN-SPECIFICITY OF PERTUSSIS AGGLUTININS FOLLOWING WHOLE-CELL PERTUSSIS VACCINATION AND INFECTION WITH BORDETELLA-PERTUSSIS
    MINK, CM
    OBRIEN, CH
    WASSILAK, S
    DEFOREST, A
    MEADE, BD
    INFECTION AND IMMUNITY, 1994, 62 (03) : 1118 - 1120
  • [3] Genomic epidemiology of Iranian Bordetella pertussis: 50 years after the implementation of whole cell vaccine
    Safarchi, Azadeh
    Octavia, Sophie
    Nikbin, Vajihe Sadat
    Lotfi, Masoumeh Nakhost
    Zahraei, Seyed Mohsen
    Tay, Chin Yen
    Lamichhane, Binit
    Shahcheraghi, Fereshteh
    Lan, Ruiting
    EMERGING MICROBES & INFECTIONS, 2019, 8 (01) : 1416 - 1427
  • [4] Strain Variation among Bordetella pertussis Isolates Circulating in Poland after 50 Years of Whole-Cell Pertussis Vaccine Use
    Mosiej, Ewa
    Augustynowicz, Ewa
    Zawadka, Monika
    Dabrowski, Waldemar
    Lutynska, Anna
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (04) : 1452 - 1457
  • [5] Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years
    Elomaa, A
    Advani, A
    Donnelly, D
    Antila, M
    Mertsola, J
    Hallander, H
    He, QS
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) : 3681 - 3687
  • [6] Bordetella pertussis Isolates Circulating in China Where Whole Cell Vaccines Have Been Used for 50 Years
    Wang, Zengguo
    He, Qiushui
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (06) : 1028 - 1029
  • [7] Impact of vaccination on the evolution of Bordetella pertussis
    Lecorvaisier, Florian
    M S-MEDECINE SCIENCES, 2024, 40 (02): : 161 - 166
  • [8] Evaluating the strategies of vaccination for Bordetella pertussis
    Joob, Beuy
    Wiwanitkit, Viroj
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2014, 112 (01): : E31 - E32
  • [9] The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in respiratory mouse model
    Heininger, U
    Stehr, K
    Cherry, JD
    VACCINE, 1998, 16 (13) : 1255 - 1255
  • [10] Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma
    Ennis, DP
    Cassidy, JP
    Mahon, BP
    IMMUNOLOGY LETTERS, 2005, 97 (01) : 91 - 100